Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00228475 |
The purpose to measure the concentration of budesonide in breast milk of asthmatic mothers on their normal maintenance treatment with budesonide (Pulmicort Turbuhaler), and to estimate the exposure of budesonide to infants.
Condition | Intervention | Phase |
---|---|---|
Asthma |
Drug: Pulmicort (budesonide) Turbuhaler |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Pharmacokinetics Study |
Official Title: | An Open Single Centre Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women on Maintenance Treatment w/Pulmicort ® Turbuhaler ® at the Dose Levels 200/400 µg Bid |
Estimated Enrollment: | 8 |
Study Start Date: | September 2004 |
Study Completion Date: | October 2005 |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | D5254C00763 |
Study First Received: | September 27, 2005 |
Last Updated: | March 24, 2009 |
ClinicalTrials.gov Identifier: | NCT00228475 History of Changes |
Health Authority: | Sweden: Medical Products Agency |
Anti-Inflammatory Agents Hormone Antagonists Budesonide Hormones, Hormone Substitutes, and Hormone Antagonists Asthma Anti-Asthmatic Agents Glucocorticoids |
Hormones Naphazoline Guaifenesin Phenylpropanolamine Peripheral Nervous System Agents Bronchodilator Agents |
Anti-Inflammatory Agents Respiratory System Agents Physiological Effects of Drugs Budesonide Hormones, Hormone Substitutes, and Hormone Antagonists Anti-Asthmatic Agents Glucocorticoids |
Hormones Pharmacologic Actions Autonomic Agents Therapeutic Uses Peripheral Nervous System Agents Bronchodilator Agents |